VentiRx raises $25 million

VentiRx Pharmaceuticals Inc. (San Diego, Calif.) raised $25 million in an extension of its series A round, bringing the total raised in the round to $51.6 million. New investor MedImmune Ventures led the extension, with participation from existing investors Arch Venture Partners; Domain Associates; and Frazier Healthcare Ventures. MedImmune Ventures' Maggie LeFlore will join VentiRx's board. ...